Doxifluridine - Aida Pharmaceuticals
Alternative Names: 5'-deoxy-5-fluorouridine; 5-deoxy-fluorordineLatest Information Update: 02 Oct 2021
At a glance
- Originator Aida Pharmaceuticals
- Class Antineoplastics; Pyrimidine nucleosides; Small molecules
- Mechanism of Action Thymidylate synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 May 2008 No development reported - Preregistration for Cancer in China (Injection)
- 30 Jun 2006 Preregistration for Cancer in China (Injection)
- 31 Dec 1998 Phase-I clinical trials in Cancer in China (Injection)